Skip to main content
Erschienen in: Intensive Care Medicine 6/2004

01.06.2004 | Experimental

Hyperbaric oxygen therapy prevents vascular derangement during zymosan-induced multiple-organ-failure syndrome

verfasst von: Francesco Imperatore, Salvatore Cuzzocrea, Carlo Luongo, Giovanni Liguori, Antonella Scafuro, Antonella De Angelis, Francesco Rossi, Achille P. Caputi, Amelia Filippelli

Erschienen in: Intensive Care Medicine | Ausgabe 6/2004

Einloggen, um Zugang zu erhalten

Abstract

Objective

This study investigated the effects of hyperbaric oxygen (HBO) therapy on the cardiovascular alteration (e.g. mean arterial pressure, vascular reactivity of thoracic aorta rings changes) caused by zymosan in rats.

Design

Rats.

Setting

University research laboratory.

Intervention and measurements

We investigated the effects of HBO therapy (2 ATA at the fourth and eleventh hours after study onset) on the cardiovascular alteration caused by zymosan (500 mg/kg, administered i.p. as a suspension in saline) in rats. Cardiovascular alterations were assessed 18 h after administration of zymosan and/or HBO therapy.

Results

Treatment of rats with HBO therapy attenuated the vasoplegic response to zymosan. In fact, the analysis of arterial pressure curves revealed no signs of vasoplegic shock. The aorta rings of animals treated with zymosan and HBO had a significantly increased contraction to norepinephrine (NE) and endothelin-1 (ET-1) and dilation to acetylcholine (ACh) compared with the zymosan group. The HBO therapy also attenuated the increase of malondialdehyde (MDA) levels caused by zymosan in the aorta. Immunohistochemical analysis for nitrotyrosine and for iNOS revealed positive staining in the aorta from zymosan-treated rats. The degree of staining for nitrotyrosine and iNOS was markedly reduced in tissue sections obtained from zymosan-rats treated with HBO therapy.

Conclusion

This study provides the first evidence that HBO therapy attenuates the degree of zymosan-induced cardiovascular derangement in the rat.
Literatur
1.
Zurück zum Zitat Cohen IL (1993) Definition of sepsis and organ failure. The ACCP/SCCM Consensus Conference Committee Report. Chest 103:656–666 Cohen IL (1993) Definition of sepsis and organ failure. The ACCP/SCCM Consensus Conference Committee Report. Chest 103:656–666
2.
Zurück zum Zitat Bone RC (1991) The pathogenesis of sepsis. Ann Med Int 115:457–469 Bone RC (1991) The pathogenesis of sepsis. Ann Med Int 115:457–469
3.
Zurück zum Zitat Hunt BJ (1998) Endothelial cell activation. Br Med J 316:1328–1329 Hunt BJ (1998) Endothelial cell activation. Br Med J 316:1328–1329
4.
Zurück zum Zitat Damas J, Remacle-Volon G, Bourdon V (1993) Platelet–activating factor and vascular effects of zymosan in rats. Eur J Pharmacol 231:231–236CrossRefPubMed Damas J, Remacle-Volon G, Bourdon V (1993) Platelet–activating factor and vascular effects of zymosan in rats. Eur J Pharmacol 231:231–236CrossRefPubMed
5.
Zurück zum Zitat Mainous M, Patrick T, Rodney D (1991) Studies of route, magnitude and time course of bacterial translocation in a model of systemic inflammation. Arch Surg 126:33–39PubMed Mainous M, Patrick T, Rodney D (1991) Studies of route, magnitude and time course of bacterial translocation in a model of systemic inflammation. Arch Surg 126:33–39PubMed
6.
Zurück zum Zitat Cuzzocrea S, Filippelli A, Zingarelli B, Falciani M, Caputi AP, Rossi F (1997) Role of nitric oxide in a non-septic shock model induced by zymosan in the rat. Shock 7:351–357PubMed Cuzzocrea S, Filippelli A, Zingarelli B, Falciani M, Caputi AP, Rossi F (1997) Role of nitric oxide in a non-septic shock model induced by zymosan in the rat. Shock 7:351–357PubMed
7.
Zurück zum Zitat Asmuth EJU von, Maessen JG, Van Der Linden CJ (1990) Tumor necrosis factor alpha (TNFα) and interleukin 6 in zymosan-induced shock model. Scand J Immunol 32:313–319PubMed Asmuth EJU von, Maessen JG, Van Der Linden CJ (1990) Tumor necrosis factor alpha (TNFα) and interleukin 6 in zymosan-induced shock model. Scand J Immunol 32:313–319PubMed
8.
Zurück zum Zitat Luongo C, Imperatore F, Cuzzocrea S (1998) Effects of hyperbaric oxygen exposure on zymosan-induced shock model. Crit Care Med 26:1972–1976CrossRefPubMed Luongo C, Imperatore F, Cuzzocrea S (1998) Effects of hyperbaric oxygen exposure on zymosan-induced shock model. Crit Care Med 26:1972–1976CrossRefPubMed
9.
Zurück zum Zitat Rogatsky GG, Shifrin EG, Mayevsky A (1999) Physiologic and biochemical monitoring during hyperbaric oxygenation: a review. Undersea Hyperb Med 26:111–122PubMed Rogatsky GG, Shifrin EG, Mayevsky A (1999) Physiologic and biochemical monitoring during hyperbaric oxygenation: a review. Undersea Hyperb Med 26:111–122PubMed
10.
Zurück zum Zitat Larsson A, Engstrom M, Uusijarvi J, Kihlstrom L, Lind F, Mathiesen T (2002) Hyperbaric oxygen treatment of postoperative neurosurgical infections. Neurosurgery. 50:287–295 Larsson A, Engstrom M, Uusijarvi J, Kihlstrom L, Lind F, Mathiesen T (2002) Hyperbaric oxygen treatment of postoperative neurosurgical infections. Neurosurgery. 50:287–295
11.
Zurück zum Zitat MacFarlane C, Cronje FJ, Benn CA (2000) Hyperbaric oxygen in trauma and surgical emergencies. J R Army Med Corps 146:185–190PubMed MacFarlane C, Cronje FJ, Benn CA (2000) Hyperbaric oxygen in trauma and surgical emergencies. J R Army Med Corps 146:185–190PubMed
12.
Zurück zum Zitat Kovskin VB, Balashov NV, Makarov FN (1995) Design and reactivity of large arterial walls in monkeys after prolonged hyperbaria. Dokl Akad Nauk 340:559–562PubMed Kovskin VB, Balashov NV, Makarov FN (1995) Design and reactivity of large arterial walls in monkeys after prolonged hyperbaria. Dokl Akad Nauk 340:559–562PubMed
13.
Zurück zum Zitat Luongo C, Imperatore F, Matera MG (1999) Effect of hyperbaric oxygen therapy in experimental subcutaneous and pulmonary infections due to Pseudomonas aeruginosa. Under Hyperb Med 26:21–25 Luongo C, Imperatore F, Matera MG (1999) Effect of hyperbaric oxygen therapy in experimental subcutaneous and pulmonary infections due to Pseudomonas aeruginosa. Under Hyperb Med 26:21–25
14.
Zurück zum Zitat Cuzzocrea S, Persichini T, Dugo L, Colasanti M, Musci G. (2003) Copper induces type II nitric oxide synthase in vivo. Free Radic Biol Med. 34:1253–1262 Cuzzocrea S, Persichini T, Dugo L, Colasanti M, Musci G. (2003) Copper induces type II nitric oxide synthase in vivo. Free Radic Biol Med. 34:1253–1262
15.
Zurück zum Zitat Snedecor GW, Cochran WG (1976) Statistical methods, 6th edn. The Iowa State University Press, Ames, Iowa, pp 549–561 Snedecor GW, Cochran WG (1976) Statistical methods, 6th edn. The Iowa State University Press, Ames, Iowa, pp 549–561
16.
Zurück zum Zitat Stoclet JC, Muller B, Gyorgy K, Andriantsiothaina R, Kleschyov AL (1999) The inducible nitric oxide synthase in vascular and cardiac tissue. Eur J Pharmacol 375:139–155CrossRefPubMed Stoclet JC, Muller B, Gyorgy K, Andriantsiothaina R, Kleschyov AL (1999) The inducible nitric oxide synthase in vascular and cardiac tissue. Eur J Pharmacol 375:139–155CrossRefPubMed
17.
Zurück zum Zitat Thiemermann C (1997) Nitric oxide and septic shock. Gen Pharmacol 29:159–166PubMed Thiemermann C (1997) Nitric oxide and septic shock. Gen Pharmacol 29:159–166PubMed
18.
Zurück zum Zitat McCord J (1993) Oxygen-derived free radicals. New Horizons 1:70–76PubMed McCord J (1993) Oxygen-derived free radicals. New Horizons 1:70–76PubMed
19.
Zurück zum Zitat Szabó C, Thiemermann C (1994) Invited opinion: Role of nitric oxide in haemorrhagic, traumatic and anaphylactic shock and in thermal injury. Shock 2:145–155PubMed Szabó C, Thiemermann C (1994) Invited opinion: Role of nitric oxide in haemorrhagic, traumatic and anaphylactic shock and in thermal injury. Shock 2:145–155PubMed
20.
Zurück zum Zitat Szabó C (1996) The role of peroxynitrite in the pathophysiology of shock, inflammation and ischemia-reperfusion injury. Shock 6:79–88PubMed Szabó C (1996) The role of peroxynitrite in the pathophysiology of shock, inflammation and ischemia-reperfusion injury. Shock 6:79–88PubMed
21.
Zurück zum Zitat Cuzzocrea S, Zingarelli B, Sautebin L, Rizzo A, Crisafulli C, Campo GM, Costantino G, Calapai G, Nava F, Rosa M di, Caputi AP (1997) Multiple organ failure following zymosan-induced peritonitis is mediated by nitric oxide. Shock 4:268–275 Cuzzocrea S, Zingarelli B, Sautebin L, Rizzo A, Crisafulli C, Campo GM, Costantino G, Calapai G, Nava F, Rosa M di, Caputi AP (1997) Multiple organ failure following zymosan-induced peritonitis is mediated by nitric oxide. Shock 4:268–275
22.
Zurück zum Zitat Demling R, Nayak U, Ikegami K, LaLonde C (1994) Comparison between lung and liver peroxidation and mortality after zymosan peritonitis in the rats. Shock 2:222–227PubMed Demling R, Nayak U, Ikegami K, LaLonde C (1994) Comparison between lung and liver peroxidation and mortality after zymosan peritonitis in the rats. Shock 2:222–227PubMed
23.
Zurück zum Zitat Cuzzocrea S, Zingarelli B, Calapai G, Nava F, Caputi AP (1997) Zymosan-activated plasma induces paw oedema by nitric oxide and prostaglandin production. Life Sci 60:215–220PubMed Cuzzocrea S, Zingarelli B, Calapai G, Nava F, Caputi AP (1997) Zymosan-activated plasma induces paw oedema by nitric oxide and prostaglandin production. Life Sci 60:215–220PubMed
24.
Zurück zum Zitat Lancaster JR (1992) Nitric oxide in cells. Am Sci 80:248–255 Lancaster JR (1992) Nitric oxide in cells. Am Sci 80:248–255
25.
Zurück zum Zitat Rao TS, Currie JL, Shaffer AF, Isakson PC (1994) In vivo characterization of zymosan-induced mouse peritoneal inflammation. J Pharmacol Exp Ther 269:917–925PubMed Rao TS, Currie JL, Shaffer AF, Isakson PC (1994) In vivo characterization of zymosan-induced mouse peritoneal inflammation. J Pharmacol Exp Ther 269:917–925PubMed
26.
Zurück zum Zitat Cuzzocrea S, Imperatore F, Costantino G, Luongo C, Mazzon E, Scafuro MA, Mangoni G, Caputi AP, Rossi F, Filippelli A (2000) Role of hyperbaric oxygen exposure in reduction of lipid peroxidation and in multiple organ failure induced by zymosan administration in the rat. Shock 13:197–203PubMed Cuzzocrea S, Imperatore F, Costantino G, Luongo C, Mazzon E, Scafuro MA, Mangoni G, Caputi AP, Rossi F, Filippelli A (2000) Role of hyperbaric oxygen exposure in reduction of lipid peroxidation and in multiple organ failure induced by zymosan administration in the rat. Shock 13:197–203PubMed
27.
Zurück zum Zitat Teixeira TJ, Williams PG, Hellewell PG (1993) Role of prostaglandins and nitric oxide in acute inflammatory reactions in guinea-pig skin. Br J Pharmacol 110:416–422PubMed Teixeira TJ, Williams PG, Hellewell PG (1993) Role of prostaglandins and nitric oxide in acute inflammatory reactions in guinea-pig skin. Br J Pharmacol 110:416–422PubMed
28.
Zurück zum Zitat Xia Y, Dawson VL, Dawson TM, Snyder SH, Zweier JL (1996) Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci USA 93:6770–6774PubMed Xia Y, Dawson VL, Dawson TM, Snyder SH, Zweier JL (1996) Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci USA 93:6770–6774PubMed
29.
Zurück zum Zitat Salvemini D, Cuzzocrea S (2002) Oxidative stress in septic shock and disseminated intravascular coagulation. Free Radic Biol Med 33:1173–1185CrossRefPubMed Salvemini D, Cuzzocrea S (2002) Oxidative stress in septic shock and disseminated intravascular coagulation. Free Radic Biol Med 33:1173–1185CrossRefPubMed
30.
Zurück zum Zitat Cuzzocrea S, Riley DP, Caputi AP, Salvemini D (2001) Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 53:135–159PubMed Cuzzocrea S, Riley DP, Caputi AP, Salvemini D (2001) Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 53:135–159PubMed
31.
Zurück zum Zitat Villa LM, Salas E, Darley-Usmar M, Radomski MEW, Moncada S (1994) Peroxynitrite induces both vasodilatation and impaired vascular relaxation in the isolated perfused rat heart. Proc Natl Acad Sci USA 91:12383–12387PubMed Villa LM, Salas E, Darley-Usmar M, Radomski MEW, Moncada S (1994) Peroxynitrite induces both vasodilatation and impaired vascular relaxation in the isolated perfused rat heart. Proc Natl Acad Sci USA 91:12383–12387PubMed
32.
Zurück zum Zitat Elliott SJ (1996) Peroxynitrite modulates receptor-activated Ca2+ signaling in vascular endothelial cells. Am J Physiol 270:L954–L961PubMed Elliott SJ (1996) Peroxynitrite modulates receptor-activated Ca2+ signaling in vascular endothelial cells. Am J Physiol 270:L954–L961PubMed
33.
Zurück zum Zitat Lahat N, Bitterman H, Yaniv N, Kinarty A, Bitterman N (1995) Exposure to hyperbaric oxygen induces tumor necrosis factor-alpha (TNF alpha) secretion from rat macrophages. Clin Exp Immunol 102:655–659PubMed Lahat N, Bitterman H, Yaniv N, Kinarty A, Bitterman N (1995) Exposure to hyperbaric oxygen induces tumor necrosis factor-alpha (TNF alpha) secretion from rat macrophages. Clin Exp Immunol 102:655–659PubMed
34.
Zurück zum Zitat Beckman JS (1996) Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 9:836–844CrossRefPubMed Beckman JS (1996) Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 9:836–844CrossRefPubMed
35.
Zurück zum Zitat Szabó C, Salzman AL, Ischiropoulos H (1995) Peroxynitrite-mediated oxidation of dihydrorhodamine 123 occurs in early stages of endotoxic and hemorrhagic shock and ischemia-reperfusion injury. FEBS Lett 372:229–232CrossRefPubMed Szabó C, Salzman AL, Ischiropoulos H (1995) Peroxynitrite-mediated oxidation of dihydrorhodamine 123 occurs in early stages of endotoxic and hemorrhagic shock and ischemia-reperfusion injury. FEBS Lett 372:229–232CrossRefPubMed
36.
Zurück zum Zitat Pelaia P, Rocco M, Blasi RA de, Spadetta G, Alampi D, Araimo FS, Nicolucci S (1995) Assesssment of lipid peroxidation in hyperbaric oxygen therapy. Protective role of N-acetylcysteine. Minerva Anestesiol 61:133–139PubMed Pelaia P, Rocco M, Blasi RA de, Spadetta G, Alampi D, Araimo FS, Nicolucci S (1995) Assesssment of lipid peroxidation in hyperbaric oxygen therapy. Protective role of N-acetylcysteine. Minerva Anestesiol 61:133–139PubMed
37.
Zurück zum Zitat Buras J. (2000) Basic mechanisms of hyperbaric oxygen in the treatment of ischemia-reperfusion injury. Int Anesthesiol Clin Winter 38:91–109 Buras J. (2000) Basic mechanisms of hyperbaric oxygen in the treatment of ischemia-reperfusion injury. Int Anesthesiol Clin Winter 38:91–109
38.
Zurück zum Zitat Balentine JD (1973) Selective vulnerability of the central nervous system to hyperbaric oxygen. Adv Exp Med Biol 37A: 293–298PubMed Balentine JD (1973) Selective vulnerability of the central nervous system to hyperbaric oxygen. Adv Exp Med Biol 37A: 293–298PubMed
39.
Zurück zum Zitat Clark JM (1982) Oxygen toxicity. In: Bennett PB, Elliot DH (eds) Physiology and medicine of diving, 3rd edn. Bailliere, Tindal and Cox, London, pp 200–238 Clark JM (1982) Oxygen toxicity. In: Bennett PB, Elliot DH (eds) Physiology and medicine of diving, 3rd edn. Bailliere, Tindal and Cox, London, pp 200–238
40.
Zurück zum Zitat Mayevsky A (1984) Invited review: brain oxygen toxicity. In: Bachrach AJ, Matzen MM (eds) Undersea physiology, vol 8. Undersea Medical Society, Bethesda, Maryland, pp 69–89 Mayevsky A (1984) Invited review: brain oxygen toxicity. In: Bachrach AJ, Matzen MM (eds) Undersea physiology, vol 8. Undersea Medical Society, Bethesda, Maryland, pp 69–89
41.
Zurück zum Zitat Piantadosi CA, Tatro LG (1990) Regional H2O2 concentration in rat brain after hyperoxic convulsions. J Appl Physiol 69:1761–1766 Piantadosi CA, Tatro LG (1990) Regional H2O2 concentration in rat brain after hyperoxic convulsions. J Appl Physiol 69:1761–1766
Metadaten
Titel
Hyperbaric oxygen therapy prevents vascular derangement during zymosan-induced multiple-organ-failure syndrome
verfasst von
Francesco Imperatore
Salvatore Cuzzocrea
Carlo Luongo
Giovanni Liguori
Antonella Scafuro
Antonella De Angelis
Francesco Rossi
Achille P. Caputi
Amelia Filippelli
Publikationsdatum
01.06.2004
Verlag
Springer-Verlag
Erschienen in
Intensive Care Medicine / Ausgabe 6/2004
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-003-2138-8

Weitere Artikel der Ausgabe 6/2004

Intensive Care Medicine 6/2004 Zur Ausgabe

Announcements

June 2004

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.